Jump to Content
ADGC
Alzheimer's Disease
Genetics Consortium
Home
ADGC Core Projects
Contact
About
Program Overview
Members
Committees
Links
Alzheimer's Disease
Acknowledgements
Collaborative Data Access (SAGs)
SAG Proposal Instructions
SAG Overview
Current ADGC Special Analysis Group Projects (SAGs)
Publications
ADGC Publications
Publications Supported by the ADGC
Publications Using ADGC and IGAP Summary Statistics
For Members
Login
You are here
Home
» ADGC Publications
ADGC Publications
Found 49 results
Filters:
Keyword
is
Humans
and
Author
is
Schellenberg, Gerard D
[Clear All Filters]
2023
Kang M
,
Ang TFang Alvin
,
Devine SA
,
Sherva R
,
Mukherjee S
,
Trittschuh EH
,
Gibbons LE
,
Scollard P
,
Lee M
,
Choi S-E
et al.
. 2023.
A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.
.
Mol Neurodegener. 18(1):40.
2022
Kuksa PP
,
Liu C-L
,
Fu W
,
Qu L
,
Zhao Y
,
Katanic Z
,
Clark K
,
Kuzma AB
,
Ho P-C
,
Tzeng K-T
et al.
. 2022.
Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.
.
J Alzheimers Dis. 86(1):461-477.
Hopfner F
,
Tietz AK
,
Ruf VC
,
Ross OA
,
Koga S
,
Dickson D
,
Aguzzi A
,
Attems J
,
Beach T
,
Beller A
et al.
. 2022.
Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.
.
Mov Disord. 37(10):2110-2121.
Holstege H
,
Hulsman M
,
Charbonnier C
,
Grenier-Boley B
,
Quenez O
,
Grozeva D
,
van Rooij JGJ
,
Sims R
,
Ahmad S
,
Amin N
et al.
. 2022.
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.
.
Nat Genet. 54(12):1786-1794.
Shade LMp
,
Katsumata Y
,
Hohman TJ
,
Nho K
,
Saykin AJ
,
Mukherjee S
,
Boehme KL
,
Kauwe JSk
,
Farrer LA
,
Schellenberg GD
et al.
. 2022.
Genome-wide association study of brain arteriolosclerosis.
.
J Cereb Blood Flow Metab. 42(8):1437-1450.
Rajabli F
,
Beecham GW
,
Hendrie HC
,
Baiyewu O
,
Ogunniyi A
,
Gao S
,
Kushch NA
,
Lipkin-Vasquez M
,
Hamilton-Nelson KL
,
Young JI
et al.
. 2022.
A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer's Disease in African Ancestry.
.
PLoS Genet. 18(7):e1009977.
Jun GR
,
You Y
,
Zhu C
,
Meng G
,
Chung J
,
Panitch R
,
Hu J
,
Xia W
,
Bennett DA
,
Foroud TM
et al.
. 2022.
Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.
.
Alzheimers Dement. 18(11):2042-2054.
Eissman JM
,
Dumitrescu L
,
Mahoney ER
,
Smith AN
,
Mukherjee S
,
Lee ML
,
Scollard P
,
Choi SEun
,
Bush WS
,
Engelman CD
et al.
. 2022.
Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
.
Brain. 145(7):2541-2554.
2021
Kunkle BW
,
Schmidt M
,
Klein H-U
,
Naj AC
,
Hamilton-Nelson KL
,
Larson EB
,
Evans DA
,
De Jager PL
,
Crane PK
,
Buxbaum JD
et al.
. 2021.
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis.
.
JAMA Neurol. 78(1):102-113.
2019
Baker E
,
Sims R
,
Leonenko G
,
Frizzati A
,
Harwood JC
,
Grozeva D
,
Morgan K
,
Passmore P
,
Holmes C
,
Powell J
et al.
. 2019.
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
.
PLoS One. 14(7):e0218111.
Tan CHong
,
Bonham LW
,
Fan CChieh
,
Mormino EC
,
Sugrue LP
,
Broce IJ
,
Hess CP
,
Yokoyama JS
,
Rabinovici GD
,
Miller BL
et al.
. 2019.
Polygenic hazard score, amyloid deposition and Alzheimer's neurodegeneration.
.
Brain. 142(2):460-470.
2018
Rajabli F
,
Feliciano BE
,
Celis K
,
Hamilton-Nelson KL
,
Whitehead PL
,
Adams LD
,
Bussies PL
,
Manrique CP
,
Rodriguez A
,
Rodriguez V
et al.
. 2018.
Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.
.
PLoS Genet. 14(12):e1007791.
Bonham LW
,
Karch CM
,
Fan CC
,
Tan C
,
Geier EG
,
Wang Y
,
Wen N
,
Broce IJ
,
Li Y
,
Barkovich MJ
et al.
. 2018.
CXCR4 involvement in neurodegenerative diseases.
.
Transl Psychiatry. 8(1):73.
Broce I
,
Karch CM
,
Wen N
,
Fan CC
,
Wang Y
,
Tan CHong
,
Kouri N
,
Ross OA
,
Höglinger GU
,
Müller U
et al.
. 2018.
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.
.
PLoS Med. 15(1):e1002487.
Chen P
,
Guarino PD
,
Dysken MW
,
Pallaki M
,
Asthana S
,
Llorente MD
,
Love S
,
Vertrees JE
,
Schellenberg GD
,
Sano M
. 2018.
Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study.
.
J Geriatr Psychiatry Neurol. 31(4):177-185.
Sanchez-Contreras MY
,
Kouri N
,
Cook CN
,
Serie DJ
,
Heckman MG
,
Finch NCA
,
Caselli RJ
,
Uitti RJ
,
Wszolek ZK
,
Graff-Radford N
et al.
. 2018.
Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
.
Mol Neurodegener. 13(1):37.
Deming Y
,
Dumitrescu L
,
Barnes LL
,
Thambisetty M
,
Kunkle B
,
Gifford KA
,
Bush WS
,
Chibnik LB
,
Mukherjee S
,
De Jager PL
et al.
. 2018.
Sex-specific genetic predictors of Alzheimer's disease biomarkers.
.
Acta Neuropathol. 136(6):857-872.
2017
Höglinger GU
,
Respondek G
,
Stamelou M
,
Kurz C
,
Josephs KA
,
Lang AE
,
Mollenhauer B
,
Müller U
,
Nilsson C
,
Whitwell JL
et al.
. 2017.
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
.
Mov Disord. 32(6):853-864.
Huang K-L
,
Marcora E
,
Pimenova AA
,
Di Narzo AF
,
Kapoor M
,
Jin SChih
,
Harari O
,
Bertelsen S
,
Fairfax BP
,
Czajkowski J
et al.
. 2017.
A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.
.
Nat Neurosci. 20(8):1052-1061.
Gerstenecker A
,
Roberson ED
,
Schellenberg GD
,
Standaert DG
,
Shprecher DR
,
Kluger BM
,
Litvan I
. 2017.
Genetic influences on cognition in progressive supranuclear palsy.
.
Mov Disord. 32(12):1764-1771.
Yokoyama JS
,
Karch CM
,
Fan CC
,
Bonham LW
,
Kouri N
,
Ross OA
,
Rademakers R
,
Kim J
,
Wang Y
,
Höglinger GU
et al.
. 2017.
Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
.
Acta Neuropathol. 133(5):825-837.
2016
Allen M
,
Burgess JD
,
Ballard T
,
Serie D
,
Wang X
,
Younkin CS
,
Sun Z
,
Kouri N
,
Baheti S
,
Wang C
et al.
. 2016.
Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
.
Acta Neuropathol. 132(2):197-211.
2015
Kouri N
,
Ross OA
,
Dombroski B
,
Younkin CS
,
Serie DJ
,
Soto-Ortolaza A
,
Baker M
,
Finch NCole A
,
Yoon H
,
Kim J
et al.
. 2015.
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
.
Nat Commun. 6:7247.
Wheeler JM
,
McMillan PJ
,
Hawk M
,
Iba M
,
Robinson L
,
Xu GJ
,
Dombroski BA
,
Jeong D
,
Dichter MA
,
Juul H
et al.
. 2015.
High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
.
Acta Neuropathol Commun. 3:33.
2014
Dysken MW
,
Sano M
,
Asthana S
,
Vertrees JE
,
Pallaki M
,
Llorente M
,
Love S
,
Schellenberg GD
,
J McCarten R
,
Malphurs J
et al.
. 2014.
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
.
JAMA. 311(1):33-44.
Pages
1
2
next ›
last »